Cargando…
MSCs loaded with oncolytic reovirus: migration and in vivo virus delivery potential for evaluating anti-cancer effect in tumor-bearing C57BL/6 mice
BACKGROUND AND AIMS: Several oncolytic viruses applications have been approved in the clinic or in different phases of clinical trials. However, these methods have some rudimentary problems. Therefore, to enhance the delivery and quality of treatment, considering the advantage of cell carrier-based...
Autores principales: | Seyed-Khorrami, Seyed-Mahmood, Soleimanjahi, Hoorieh, Soudi, Sara, Habibian, Ala |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088007/ https://www.ncbi.nlm.nih.gov/pubmed/33933086 http://dx.doi.org/10.1186/s12935-021-01848-5 |
Ejemplares similares
-
Kinetics of Oncolytic Reovirus T3D Replication and Growth
Pattern in Mesenchymal Stem Cells
por: Banijamali, Razieh Sadat, et al.
Publicado: (2020) -
Past, Present and Future of Oncolytic Reovirus
por: Müller, Louise, et al.
Publicado: (2020) -
Comparative Study of The Effect of LPS on The Function of
BALB/c and C57BL/6 Peritoneal Macrophages
por: Soudi, Sara, et al.
Publicado: (2013) -
EO771, the first luminal B mammary cancer cell line from C57BL/6 mice
por: Le Naour, Augustin, et al.
Publicado: (2020) -
Oncolytic Reovirus in Canine Mast Cell Tumor
por: Hwang, Chung Chew, et al.
Publicado: (2013)